HuffPost Canada closed in 2021 and this site is maintained as an online
archive. If you have questions or concerns, please check our
FAQ or contact
support@huffpost.com.
drug patents
Much of NAFTA remains intact under the new USMCA, but life will change in some ways for consumers.
Chief negotiator slammed for "complete misunderstanding" of CETA's impact on drug prices.
It is Canada's challenge to ensure this country is attractive to those who are making the decisions on where to invest their dollars for the discovery and development of innovative new treatments. So while critics try to dismiss stronger IP as nothing more than a technique to pad the bottom line of a faceless corporation, for millions of Canadians it could be a matter of life and breath.
Should the government be allowed to force pharmaceutical companies to continue manufacturing drugs that are no longer profitable, if these drugs are in the public best interest? I'm really struggling with this one.
The current rush to approve medicines while manufacturers' "patent clocks" are ticking means that some medicines make it to market that later must be recalled because of harms they cause to patients -- harms that could be detected with more thorough pre-market evaluation.
